SCHEMBL4920355

SCHEMBL4920355

c1coc(-c2cccn3ccnc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 6/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 6/20 0.37
POLB P06746 3/20 0.37
BLM P54132 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
CASP1 P29466 1/20 0.37
PTPN7 P35236 1/20 0.37
BRCA1 P38398 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4930253 0.78 HSD17B10 (0.41) HSD17B10MAPK1ALDH1A1MEN1KMT2A
SCHEMBL13574557 0.73 FYN (0.38) HSD17B10ALDH1A1MEN1KMT2AUSP2
SCHEMBL3315531 0.73 NUDT1 (0.42) MEN1KMT2ABLMTHRBTDP1
SCHEMBL8545080 0.73 ALDH1A1 (0.54) HSD17B10MAPK1ALDH1A1MEN1KMT2A
SCHEMBL7086846 0.72 ELANE (0.36) HSD17B10MAPK1ALDH1A1MEN1KMT2A
SCHEMBL20388085 0.72 FADS1 (0.35) NUDT1ADRA1AADRA1B
SCHEMBL4672079 0.72 ALDH1A3 (0.54) HSD17B10ALDH1A1KDM4EHPGDNPC1
SCHEMBL7308381 0.72 JAK2 (0.50) LMNAMAPTADORA2ANUDT1ADRA1A
SCHEMBL1431759 0.71 TNKS (0.47) ALDH1A1MEN1KMT2AKDM4EPOLB
SCHEMBL7311083 0.69 KDM4E (0.45) HSD17B10MAPK1ALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080219922-A1 Alzheimer's Disease Imaging Agents EMORY UNIVERSITY 2008-09-11 US disclosed
WO-2007033080-A2 ALZHEIMER'S DISEASE IMAGING AGENTS EMORY UNIVERSITY (US) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080219922-A1 Alzheimer's Disease Imaging Agents APP, PSEN1, MAPT HSD17B10 3256/4885MAPK1 2409/4885ALDH1A1 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.